Fukuoka, Japan
Fukuoka, Japan

Kyushu University , abbreviated to Kyudai , is a Japanese public university located in Fukuoka, Kyushu. It is one of Japan's National Seven Universities . The history of Kyushu University can be traced by medical schools of the feudal domains built in 1867, and is the largest public university in Kyushu.There are 1,292 foreign students enrolled in the University. It was chosen for the Global 30 university program, and has been selected to the top 13 global university project. Wikipedia.


Time filter

Source Type

Patent
Kyushu University and Nippon Chemiphar Co. | Date: 2016-10-28

A P2X_(4 )receptor antagonist such as paroxetine, a diazepinedione derivative having the following formula (IX) is used as an agent for preventing or treating neuropathic pain associated with Guillain-Barr syndrome: wherein R^(1 )is hydrogen, a C_(1-8 )alkyl group, or the like;


Patent
Kyowa Hakko Kirin Co. and Kyushu University | Date: 2016-12-09

Disclosed are an anti-human TIM-3 antibody having high ADCC activity or antibody fragment thereof by screening a monoclonal antibody or antibody fragment thereof which binds to the amino acid sequence of the extracellular region of TIM-3 or its three-dimensional structure and exhibits ADCC activity; a hybridoma which produces the antibody; a DNA encoding the antibody; a vector comprising the DNA; a transformant which is obtainable by introducing the vector; a method for producing the antibody or the antibody fragment thereof which comprises using the hybridoma or the transformant; and a therapeutic agent and a diagnostic agent comprising the antibody or the antibody fragment thereof as an active ingredient.


Patent
AutoNetworks Technologies Ltd., Sumitomo Wiring Systems Ltd., Sumitomo Electric Industries and Kyushu University | Date: 2015-01-29

An adhesive composition that is capable of functioning alone as an adhesive component without using a curable resin, and adhering to integrate an inorganic material and an organic material, and a composite material using the same. The adhesive composition contains an adduct containing an acidic phosphate ester comprising one or more kinds of compounds represented by General Formulae (1) and (2), and a metal. The composite material includes one material, the other material, and an adhesive composition disposed between the materials to adhere to the materials, the one material and the other material being integrated by the adhesive composition. P(O)(OR_(1))(OH)_(2 ). . . (1), and P(O)(OR_(1))_(2)(OH) . . . (2), where R_(1 )represents an aliphatic hydrocarbon group having 4 to 30 carbon atoms, and has one or more branched chain structures, or one or more carbon-carbon double bond structures.


Patent
Kyushu University and Shin - Etsu Chemical Co. | Date: 2015-03-03

A neutral or cationic mononuclear ruthenium divalent complex represented by formula (1) can actualize exceptional catalytic activity in at least one reaction among a hydrosilylation reaction, hydrogenation reaction, and carbonyl compound reduction reaction. (In the formula, R^(1)-R^(6 )each independently represent a hydrogen atom or an alkyl group, aryl group, aralkyl group, organooxy group, monoorganoamino group, diorganoamino group, monoorganophosphino group, diorganophosphino group, monoorganosilyl group, diorganosilyl group, triorganosilyl group, or organothio group optionally substituted by X; at least one pair comprising any of R^(1)-R^(3 )and any of R^(4)-R^(6 )together represents a crosslinkable substituent; X represents a halogen atom, organooxy group, monoorganoamino group, diorganoamino group, or organothio group; L each independently represent a two-electron ligand other than CO and thiourea ligands; two L may bond to each other; and m represents an integer of 3 or 4.)


Patent
Kyushu University and Shin - Etsu Chemical Co. | Date: 2017-01-18

A neutral or cationic mononuclear ruthenium divalent complex represented by formula (1) can actualize exceptional catalytic activity in at least one reaction among a hydrosilylation reaction, hydrogenation reaction, and carbonyl compound reduction reaction.^(1)-R^(6) each independently represent a hydrogen atom or an alkyl group, aryl group, aralkyl group, organooxy group, monoorganoamino group, diorganoamino group, monoorganophosphino group, diorganophosphino group, monoorganosilyl group, diorganosilyl group, triorganosilyl group, or organothio group optionally substituted by X; at least one pair comprising any of R^(1)-R^(3) and any of R^(4)-R^(6) together represents a crosslinkable substituent; X represents a halogen atom, organooxy group, monoorganoamino group, diorganoamino group, or organothio group; L each independently represent a two-electron ligand other than CO and thiourea ligands; two L may bond to each other; and m represents an integer of 3 or 4.)


Provided is a redox catalyst wherein a catalytically active component is supported on carbon nanotubes whose average diameter (Av) and standard deviation () of diameters satisfy the condition 0.60>3/Av>0.20, and at least a part of a surface of the carbon nanotubes, including a part on which the catalytically active component is supported, is covered with porous inorganic material.


Patent
Kyushu University and Nippon Chemiphar Co. | Date: 2017-02-22

A P2X_(4) receptor antagonist such as paroxetine, a diazepinedione derivative having the following formula (IX) is used as an agent for preventing or treating zoster-associated pain in acute phase:^(1) is hydrogen, a C_(1-8) alkyl group, or the like;each of R^(2) and R^(3) is hydrogen, a C_(1-8) alkyl group, or the like;each of R^(4) and R^(5) is hydrogen or the like; andW is a five-membered or six-membered heterocyclic ring optionally having one or more substituents and comprising one to four nitrogen atoms as the members of the ring.


Patent
Nippon Paper Industries Co. and Kyushu University | Date: 2017-03-01

An object of the present invention is to find a component that is safe and is capable of effectively exerting various effects such as prevention or amelioration of diabetes, prevention or amelioration of metabolic syndrome, amelioration of insulin resistance, inhibition of an increase in a postprandial blood sugar level, and inhibition of -glucosidase activity. The present invention provides agents for preventing or ameliorating diabetes or the like, the agents including a component of a hybrid plant of Camellia sinensis and Camellia taliensis as an active ingredient. The hybrid plant is preferably Sun Rouge, and each of the agents preferably includes a tea leaf extract of the hybrid plant.


Patent
University of Tokyo, Kyushu University and NH Foods Ltd. | Date: 2017-02-01

An anti-aging agent derived from a natural product is provided. The agent uses at least one selected from the group consisting of an imidazole dipeptide and a metabolite thereof as an active ingredient. The present invention also provides an agent for improving a neuropsychologic function, which contains at least one selected from the group consisting of an imidazole dipeptide and a metabolite thereof as an active ingredient. The present invention also provides an agent for changing expression of a transporter such as SLC23A2, which contains at least one selected from the group consisting of an imidazole dipeptide and a metabolite thereof, and an agent for controlling blood concentration of a cytokine such as IP-10, which contains at least one selected from the group consisting of an imidazole dipeptide and a metabolite thereof, as well as an expression analysis method for detecting improvement or degradation of a neuropsychologic function, and a kit for detecting improvement or degradation of a neuropsychologic function.


Patent
Kyushu University | Date: 2017-02-01

Provided is a catalyst for transesterification reactions, which contains an iron salen complex. Also provided is a method for producing an ester compound, which is characterized by carrying out a transesterification reaction between a starting material ester and a starting material alcohol with use of the catalyst.

Loading Kyushu University collaborators
Loading Kyushu University collaborators